Pharmaceutical Validation Articles from NIR news
Volume 17 Issue 5 Pages 10–14 (2006)
doi: 10.1255/nirn.905 Implementation of near infrared and Raman spectroscopy
for tablet composition and relative density analysis for a four-component system Steven M. Short, Robert P. Cogdill and Carl A. Anderson Duquesne
University, Duquesne Center for Pharmaceutical Technology, 600 Forbes Ave, Pittsburgh, PA 15282, USA
Volume 17 Issue 2 Pages 4–6 (2006)
doi: 10.1255/nirn.878 A theoretical framework for real time release with NIR and
chemometrics Erik Skibsted,a,b Johan Westerhuis,a Age Smildea,c and D.T. Witted aCMC
Development, Novo Nordisk A/S, DK-2760 Maaloev, Denmark. E-mail: ersk@novonordisk.com bBiosystems Data Analysis, Faculty of Science, University of
Amsterdam, Nieuwe Achtergracht 166, 1018 WV, The Netherlands cTNO Quality of Life, Utrechtseweg 48, 3700 AJ Zeist, The
Netherlands dQA/ALC-A, N.V. Organon, Molenstraat 10, PO Box 20, 5340 BH Oss, The Netherlands
Volume 16 Issue 7 Pages 23–26 (2005)
doi: 10.1255/nirn.858 Near infrared spectroscopy in the pharmaceutical industry Robert P. Cogdill and James K. Drennen, III Duquesne University, Center for Pharmaceutical Technology, Pittsburgh, PA, USA
Volume 16 Issue 5 Pages 15–15 (2005)
doi: 10.1255/nirn.839 Current thoughts on the PAT initiative. James K.
Drennen, III Duquesne University Center for Pharmeceutical technology, Pittsburgh, PA 15282, USA
Volume 16 Issue 4 Pages 6–15 (2005)
doi: 10.1255/nirn.826 A prevention based strategy for quality control using PAT Philip Lunneya,b and James K. Drennen, III aDuquesne University, Center for Pharmaceutical Technology, Pittsburgh, PA, USA
Volume 16 Issue 3 Pages 7–8 (2005)
doi: 10.1255/nirn.817 Statistical experimental design for PAT method
development Carl A. Anderson, Robert P. Cogdill and James K. Drennen, III Duquesne University Center for Pharmaceutical Technology, Pittsburgh, PA,
Duquesne University, USA
Volume 16 Issue 2 Pages 14–15 (2005)
doi: 10.1255/nirn.813 Efficient NIR calibrations utilising pure component
projection. Carl A. Anderson and Robert P. Cogdill Duquesne University Center for Pharmaceutical Technology, Pittsburgh, PA,, USA
Volume 15 Issue 6 Pages 13–15 (2004)
doi: 10.1255/nirn.796 Calibration transfer in pharmaceutical near infrared
spectroscopy Mark R. Smith Centre for Pharmaceutical Analysis, The School of Pharmacy, University of London, 29/39 Brunswick Square, London WC1N
1AX, UK
Volume 15 Issue 5 Pages 12–13 (2004)
doi: 10.1255/nirn.787 Risk analysis for near infrared method development. Robert P. Cogdill, Carl A. Anderson and James K. Drennen, III Duquesne University Center for Pharmaceutical Technology, Pittsburgh, PA 15282, USA
Volume 15 Issue 4 Pages 9–10 (2004)
doi: 10.1255/nirn.777 Critical concerns for implementing Process Analytical
Technologies in the pharmaceutical industry James K. Drennen, Carl A. Anderson and Robert P. Cogdill Duquesne University Center for Pharmaceutical
Technology, Pittsburgh, PA 15282, USA, E-mail: drennen@duq.edu
Volume 15 Issue 3 Pages 8–9 (2004)
doi: 10.1255/nirn.767 The dissolution profile of USP non-disintegrating
calibrator tablets using near infrared spectroscopy Randall J. Voytilla andJames K. Drennen Duquesne University Center for Pharceutical Technology,
Pittsburgh, PA 15282, USA, E-mail: drennen@duq.edu
Volume 15 Issue 2 Pages 9–11 (2004)
doi: 10.1255/nirn.758 PAT methods provide process understanding Arwa S. El-Hagrasy and James K. Drennen Duquesne University Center for Pharmaceutical Technology, Pittsburgh, PA 15282, USA. E-mail: drennen@duq.edu
Volume 15 Issue 1 Pages 16–16 (2004)
doi: 10.1255/nirn.754 New ASTM Activity on Pharmaceutical Application of
Process Analytical Technology Jim Drennen Duquesne University Center for Pharceutical Technology, Pittsburgh, PA 15282, USA, E-mail:
drennen@duq.edu
Volume 14 Issue 6 Pages 7–8 (2003)
doi: 10.1255/nirn.741 Pharmaceutical Validation. Near infrared spectroscopy for
determining the hardness of roller compacted briquettes Vishal Bijlani, Carl Anderson, Christianah Adeyeye and Jim Drennen Duquesne University Center for
Pharceutical Technology, Pittsburgh, PA 15282, USA, E-mail: drennen@duq.edu
Volume 14 Issue 5 Pages 14–15 (2003)
doi: 10.1255/nirn.736 Pharmaceutical Validation. Calibration transfer: a critical
component of analytical method validation Jim Drennen Duquesne University Center for Pharceutical Technology, Pittsburgh, PA 15282, USA, E-mail:
drennen@duq.edu
Volume 14 Issue 4 Pages 14–0 (2003)
doi: 10.1255/nirn.728 Pharmaceutical Validation. PASG NIR Sub-Group update Neville Broad
Volume 14 Issue 3 Pages 14–0 (2003)
doi: 10.1255/nirn.720 Pharmaceutical Validation. Comparability protocols:
chemistry, manufacturing and controls information Jim Drennen and Carl Andersen Duquesne University, USA
Volume 14 Issue 2 Pages 22–0 (2003)
doi: 10.1255/nirn.711 Pharmaceutical Validation. In situ spectroscopic cleaning
validation Aaron A. Urbas and Robert A. Lodder University of Kentucky, USA
Volume 13 Issue 5 Pages 8–0 (2002)
doi: 10.1255/nirn.680 Pharmaceutical Validation. Near infrared spectroscopy for
monitoring the hardness of roller compacted ribbons Vishal J. Bijlani Duquesne University, USA
Volume 13 Issue 4 Pages 8–0 (2002)
doi: 10.1255/nirn.669 Pharmaceutical Validation. Non-destructive tablet hardness
testing: the effect of moisture on tablet hardness prediction James K. Drennen III and Randall J. Voytilla Duquesne University, USA
Volume 13 Issue 3 Pages 12–0 (2002)
doi: 10.1255/nirn.665 Pharmaceutical Validation. The FDA is coming!! The FDA is
coming!! Howard Mark Mark Electronics, USA
Volume 13 Issue 2 Pages 14–0 (2002)
doi: 10.1255/nirn.659 Pharmaceutical Validation. Process analytical technologies James K. Drennen III Duquesne University, USA
Volume 13 Issue 1 Pages 12–0 (2002)
doi: 10.1255/nirn.648 Pharmaceutical NIR spectroscopy: a state of enthusiastic
anticipation Gary E. Ritchie Purdue Pharma L.P, USA
Volume 12 Issue 6 Pages 10–0 (2001)
doi: 10.1255/nirn.640 Pharmaceutical Validation. Proving the specificity of your
NIR method James K. Drennen Duquesne University, USA
Volume 12 Issue 5 Pages 13–0 (2001)
doi: 10.1255/nirn.632 Pharmaceutical Validation. Proposed <1119> Revision James K. Drennen Duquesne University, USA
Volume 12 Issue 4 Pages 7–0 (2001)
doi: 10.1255/nirn.623 Pharmaceutical Validation. The PASG validation guidelines
for NIR methods in the pharmaceutical industry Ken Prebble GlaxoSmithKline, UK
Volume 12 Issue 2 Pages 5–0 (2001)
doi: 10.1255/nirn.604 Pharmaceutical Validation Column James K.
Drennen III Duquesne University, USA
|